Tech Center 1700 • Art Units: 1651 1657 1682 1792
This examiner grants 55% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17769452 | METHOD FOR EVALUATING DRUG TOXICITY | Non-Final OA | Takeda Pharmaceutical Company Limited |
| 18516616 | VARIANTS OF A DNA POLYMERASE OF THE POLX FAMILY | Non-Final OA | Centre National De La Recherche Scientifique |
| 17742035 | PRODUCTION METHOD FOR LIPID PARTICLES IN LIQUID AND METHOD FOR CULTURING MICROORGANISMS | Final Rejection | KANEKA CORPORATION |
| 18250645 | MUTANT PROTEASES AND USES THEREOF | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18681047 | METHOD FOR PRODUCTION OF AMMONIA, USING INORGANIC NANOPARTICLE-MICROBIAL COMPLEX | Non-Final OA | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 17597304 | SERPIN PRODUCTION | Non-Final OA | SOCIETE DES PRODUITS NESTLE S.A. |
| 18546449 | UPCYCLING OF PLASTIC WASTE TO RECOMBINANT SILK PROTEINS VIA PSEUDOMONAS BACTERIA | Non-Final OA | Rensselaer Polytechnic Institute |
| 18110973 | METHOD FOR PRODUCING ORGANIC SUBSTANCE | Final Rejection | SEKISUI CHEMICAL CO., LTD. |
| 17603978 | CATALYTICALLY INACTIVE BOTULINUM NEUROTOXIN-LIKE TOXINS AND USES THEREOF | Non-Final OA | Children's Medical Center Corporation |
| 17570104 | FUSION PROTEIN NANODISK COMPOSITIONS AND METHODS OF TREATMENT | Final Rejection | The Brigham and Women's Hospital, Inc. |
| 17641586 | BIOFILM TRANSFORMATION | Non-Final OA | Oxford University Innovation Limited |
| 18573419 | RECOMBINANT MICROORGANISM IN WHICH EXPRESSION OF NADH:QUINONE OXIDOREDUCTASE IS CONTROLLED, AND METHOD FOR PRODUCING O-PHOSPHOSERINE, CYSTEINE, AND DERIVATIVE THEREOF BY USING SAME | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 17480792 | METHOD FOR PRODUCING ALLOLACTOSE | Final Rejection | AJINOMOTO CO., INC. |
| 18844679 | A NOVEL PROTEIN COMPOSITION AND THEIR USE IN FORMULATING DAIRY PRODUCTS | Non-Final OA | PHYX44 LABS PRIVATE LIMITED |
| 18277398 | METHOD FOR PRODUCING A HYDROXYTYROSOL | Final Rejection | Wacker Chemie AG |
| 18392498 | Reducing or Inhibiting Ocular Damage by Hyaluronidase Administration | Non-Final OA | Med Progress, LLC |
| 17311262 | COMPOSITIONS FOR STABILIZING BACTERIA AND USES THEREOF | Final Rejection | Seres Therapeutics, Inc. |
| 17594994 | METHODS FOR THE FRACTIONATION OF PROTEINS | Final Rejection | THE UNIVERSITY OF SYDNEY |
| 18561525 | REDOX SENSITIVE CRALBP MUTANT PROTEINS | Non-Final OA | UNIVERSITÄT BERN |
| 18578921 | Phytase Variants | Non-Final OA | AB Enzymes Oy |
| 18551182 | MODIFIED HOST CELLS FOR HIGH EFFICIENCY PRODUCTION OF VANILLIN | Non-Final OA | AMYRIS , INC. |
| 18575597 | ENHANCED EXPRESSION OF AN AROMATIC AMINO ACID DECARBOXYLASE (AADC) IN THE SUBSTANTIA NIGRA FOR THE TREATMENT OF PARKINSON'S DISEASE | Non-Final OA | Comell University |
| 18398273 | RECOMBINANT PROTEIN CAPABLE OF RESISTING MULTIPLE SCLEROSIS AND PREPARATION METHOD AND APPLICATION THEREOF | Non-Final OA | INSTITUTE OF ZOOLOGY, GUANGDONG ACADEMY OF SCIENCES |
| 17799190 | SPRAY FREEZE DRYING OF STRICT ANAEROBIC BACTERIA | Final Rejection | Chr. Hansen A/S |
| 18569824 | COMPOSITIONS AND METHODS FOR MICROBIAL TREATMENT OF SKIN DISORDERS | Non-Final OA | IFF US Holding, LLC |
| 18279596 | A METHOD FOR PREPARATION OF alpha-GLUCAN | Non-Final OA | Xiaolin Li |
| 17294587 | MICROFLUIDIC IN VITRO MODEL FOR ELUCIDATING THE MOLECULAR EFFECTS OF SIMULATED DIETARY REGIMENS ON GUT MICROBIOTA AND HOST CELLS | Non-Final OA | Universite Du Luxembourg |
| 17610249 | POLYPEPTIDES FOR TREATMENT OF BACTERIAL INFECTIONS | Non-Final OA | CC Biotech Ltd. |
| 18010092 | ENGINEERED MAD7 DIRECTED ENDONUCLEASE | Final Rejection | BIO-TECHNE CORPORATION |
| 17907572 | SPERMIDINE-SUPPLEMENTED FOOD PRODUCTS | Non-Final OA | KALIN HEALTH LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy